PHARMACOKINETICS OF DOXORUBICIN AND ITS METABOLITE DOXORUBICINOL IN RABBITS WITH INDUCED ACID AND ALKALINE URINE

被引：14
|
作者：
JOHANSEN, PB
JENSEN, SE
RASMUSSEN, SN
DALMARK, M
机构：
[1] ROYAL DANISH SCH PHARM,DEPT BIOL,DK-2100 COPENHAGEN O,DENMARK
[2] FINSEN INST,DEPT A,RADIUM STN,DK-2100 COPENHAGEN O,DENMARK
来源：
CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1984年 / 13卷 / 01期
关键词：
D O I：
10.1007/BF00401437
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：5 / 8
页数：4
相关论文
共 50 条
  • [31] Pharmacokinetics of verapamil and its metabolite norverapamil in rats with hyperlipidaemia induced by poloxamer 407
    Lee, Young Sun
    Yoon, Ji Na
    Yoon, In-Soo
    Lee, Myung Gull
    Kang, Hee Eun
    XENOBIOTICA, 2012, 42 (08) : 766 - 774
  • [32] Pharmacokinetics of active component of Chrysanthemum morifolium extracts and its acid hydrolysate in rabbits
    Li, Li-Ping
    Jiang, Hui-Di
    Wu, Hao-Hao
    Ting, Chen
    Chinese Pharmaceutical Journal, 2005, 40 (24) : 1884 - 1887
  • [33] PHARMACOKINETICS OF LIDOCAINE AND ITS MAJOR METABOLITE - MONOETHYLGLYCINEXYLIDIDE (MEGX) IN RABBITS WITH EXPERIMENTAL COMMON BILE-DUCT OBSTRUCTION
    WOJCICKI, J
    SULIKOWSKI, T
    WOJCICKI, M
    DROZDZIK, M
    GAWRONSKASZKLARZ, B
    BARCEWWISZNIEWSKA, B
    SKOWRON, J
    ROZEWICKA, L
    GOLDYN, U
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1995, 20 (02) : 119 - 123
  • [34] Pharmacokinetics of remifentanil and its major metabolite, remifentanil acid, in ICU patients with renal impairment
    Pitsiu, M
    Wilmer, A
    Bodenham, A
    Breen, D
    Bach, V
    Bonde, J
    Kessler, P
    Albrecht, S
    Fisher, G
    Kirkham, A
    BRITISH JOURNAL OF ANAESTHESIA, 2004, 92 (04) : 493 - 503
  • [35] Effect of cyclosporine A and tacrolimus on pharmacokinetics of mycophenolic acid and its metabolite in kidney transplant recipients
    Merkel, U
    Lauerwald, W
    Sperschneider, H
    Vollandt, R
    Balogh, A
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 58 (07) : S96 - S96
  • [36] Mechanistic Study on the Effect of Renal Impairment on the Pharmacokinetics of Vildagliptin and its Carboxylic Acid Metabolite
    Guo, Zitao
    Kong, Fandi
    Xie, Ningjie
    Chen, Zhendong
    Hu, Jiafeng
    Chen, Xiaoyan
    PHARMACEUTICAL RESEARCH, 2022, 39 (09) : 2147 - 2162
  • [37] Folic acid and its metabolite codetermination for pharmacokinetics with circadian rhythms and evaluation of oral bioavailability
    Meng, Fanyue
    Zhang, Guoqing
    Wang, Caifen
    Zhu, Rui
    Li, Haiyan
    Xu, Jian
    Shakya, Shailendra
    Chen, Weidong
    Wu, Li
    Zhang, Jiwen
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2019, 71 (11) : 1645 - 1654
  • [38] Mechanistic Study on the Effect of Renal Impairment on the Pharmacokinetics of Vildagliptin and its Carboxylic Acid Metabolite
    Zitao Guo
    Fandi Kong
    Ningjie Xie
    Zhendong Chen
    Jiafeng Hu
    Xiaoyan Chen
    Pharmaceutical Research, 2022, 39 : 2147 - 2162
  • [39] Relative Quantification of the Metabolite of Aconitine in Rat Urine by LC-ESI-MS/MS and Its Application to Pharmacokinetics
    He, Huiwen
    Yan, Fei
    ANALYTICAL SCIENCES, 2012, 28 (12) : 1203 - 1205
  • [40] Population plasma and urine pharmacokinetics of ivabradine and its active metabolite S18982 in healthy Korean volunteers
    Choi, Hee Youn
    Bae, Kyun-Seop
    Cho, Sang-Heon
    Ghim, Jong-Lyul
    Choe, Sangmin
    Jung, Jin Ah
    Lim, Hyeong-Seok
    JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 56 (04): : 439 - 449
12345